X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
male (110) 110
infectious diseases (108) 108
female (105) 105
adult (101) 101
hiv infections - drug therapy (78) 78
middle aged (62) 62
immunology (61) 61
hiv (47) 47
hiv infections - complications (40) 40
microbiology (39) 39
virology (39) 39
aids (34) 34
treatment outcome (32) 32
viral load (32) 32
drug therapy, combination (31) 31
antiretroviral therapy (29) 29
human immunodeficiency virus--hiv (29) 29
hiv infections - virology (28) 28
hiv infection (27) 27
anti-hiv agents - therapeutic use (25) 25
cd4 lymphocyte count (24) 24
prospective studies (24) 24
anti-hiv agents - adverse effects (23) 23
pharmacology & pharmacy (23) 23
risk factors (23) 23
human-immunodeficiency-virus (22) 22
antiretroviral drugs (21) 21
aged (20) 20
cohort studies (20) 20
anti-hiv agents - administration & dosage (19) 19
antiretroviral therapy, highly active (19) 19
drug therapy (19) 19
mortality (19) 19
therapy (19) 19
aids/hiv (18) 18
efficacy (18) 18
hiv-1 - drug effects (18) 18
spain - epidemiology (17) 17
tenofovir (17) 17
clinical trials (16) 16
comorbidity (16) 16
hepatitis c, chronic - drug therapy (16) 16
spain (16) 16
care and treatment (15) 15
health aspects (15) 15
hepatitis c (15) 15
hepatitis c virus (15) 15
hepatitis c, chronic - complications (15) 15
ribavirin - therapeutic use (15) 15
antiviral agents - therapeutic use (14) 14
hiv infections - epidemiology (14) 14
hiv-1 (14) 14
human immunodeficiency virus (14) 14
infectious disease (14) 14
protease inhibitors (14) 14
efavirenz (13) 13
follow-up studies (13) 13
hepatitis c - drug therapy (13) 13
analysis (12) 12
hepatitis c - complications (12) 12
hiv infections - immunology (12) 12
infections (12) 12
interferon (12) 12
interferon-alpha - therapeutic use (12) 12
research (12) 12
reverse transcriptase inhibitors - therapeutic use (12) 12
ribavirin (12) 12
rna, viral - blood (12) 12
active antiretroviral therapy (11) 11
gastroenterology & hepatology (11) 11
hepatitis (11) 11
hiv-infected patients (11) 11
ribavirin - administration & dosage (11) 11
sida (11) 11
acquired immune deficiency syndrome--aids (10) 10
adenine - analogs & derivatives (10) 10
adherence (10) 10
adolescent (10) 10
antiviral agents - administration & dosage (10) 10
disease progression (10) 10
epidemiology (10) 10
hepatitis c - epidemiology (10) 10
highly active antiretroviral therapy (10) 10
hiv patients (10) 10
hiv-1 - genetics (10) 10
liver (10) 10
ritonavir - therapeutic use (10) 10
safety (10) 10
toxicity (10) 10
antiretroviral treatment (9) 9
antiviral agents (9) 9
biopsy (9) 9
hiv-1 - isolation & purification (9) 9
impact (9) 9
infection (9) 9
recommendations (9) 9
research article (9) 9
retrospective studies (9) 9
reverse transcriptase inhibitors - adverse effects (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 1, p. e14515
...Author(s): Agathe Leon 1,*, Cesar Caceres 2, Emma Fernandez 1, Paloma Chausa 2, Maite Martin 3, Carles Codina 3, Araceli Rousaud 4, Jordi Blanch 4, Josep... 
TRIAL | DEPRESSION | DISTANCE | IMPACT | MANAGEMENT | HIV | MULTIDISCIPLINARY SCIENCES | TELECARE | HOSPITAL ANXIETY | CONGESTIVE-HEART-FAILURE | ADHERENCE | Standard of Care | Telemedicine - standards | HIV Infections - virology | Humans | Home Care Services - standards | Male | CD4 Lymphocyte Count | Viral Load | Antiretroviral Therapy, Highly Active | HIV-1 - physiology | Telemedicine - methods | HIV Infections - therapy | Adult | Female | Chronic Disease | Telemedicine - instrumentation | Home care | Medical research | Clinics | Chronic diseases | HIV patients | T cells | HIV (Viruses) | Digital libraries | User groups | Telemedicine | Analysis | Medicine, Experimental | Medical care | Cross infection | Nosocomial infections | Health aspects | HIV infection | Quality management | Developed countries | Health care | Bioengineering | Virtual libraries | Blood tests | Clinical trials | Chronic infection | African Americans | Viruses | Lymphocytes T | Infections | Randomization | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Nurses | Human immunodeficiency virus--HIV | Chronic illnesses | Medical personnel | Evaluation | Broadband | Patients | Antiretroviral therapy | CD4 antigen | Quality of life | Disease prevention | Infectious diseases | Hospitals | Cellular telephones | Pharmacy | Health care access | Diabetes | Drug stores | Malalties cròniques | HIV-positive persons | Telecommunication in medicine | Persones seropositives | Telecomunicació en medicina | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1087 - 1097
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 5, pp. 728 - 736
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 7, pp. 597 - 605
Summary Background Rates of sustained virological response (SVR) to peginterferon–ribavirin are low in patients with hepatitis C virus (HCV) genotype 1 and... 
Infectious Disease | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Recombinant Proteins - adverse effects | Viral Load | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Drug Therapy, Combination - adverse effects | HIV-1 - isolation & purification | Placebos - adverse effects | Ribavirin - administration & dosage | Adult | Female | Placebos - administration & dosage | Proline - administration & dosage | Hepacivirus - isolation & purification | Double-Blind Method | Proline - analogs & derivatives | HIV Infections - virology | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | HIV Infections - complications | Aged | Hepacivirus - classification | Interferon-alpha - adverse effects | Medical colleges | Interferon alpha | Clinical trials | HIV (Viruses) | Biological response modifiers | Ribavirin | Viral antigens | Virus diseases | Genetic aspects | Product development | Drug therapy | Hepatitis C virus | HIV infection
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 785 - 792
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 2017, Volume 92, pp. 42 - 47
Journal Article
The lancet HIV, ISSN 2352-3018, 2015, Volume 2, Issue 8, pp. e319 - e327
Journal Article
PloS one, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0145701
Journal Article
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 12, pp. 1578 - 1585
Journal Article
by Sobrino-Vegas, Paz and Monge Corella, Susana and Serrano-Villar, Sergio and Gutiérrez, Félix and Masiá, Mar and López Rodríguez, Cristina and Padilla, Sergio and Navarro, Andrés and Montolio, Fernando and Robledano García, Catalina and Colomé, Joan Gregori and Blanco, José Ramón and Santos, Ignacio and Del Romero, Jorge and Segura, Ferrán and Portilla, Joaquín and Guillén, Santiago Moreno and Del Amo, Julia and García, Federico and Ángeles Muñoz, María and Hernando Sebastián, Victoria and Alejos Ferreras, Belén and Álvarez, Débora and Monge, Susana and Jarrín, Inmaculada and Rivero, Yaiza and González Blázquez, Cristina and Muñoz-Fernández, M. Ángeles and García-Merino, Isabel and Gómez Rico, Coral and Gallego De La Fuente, Jorge and García Torre, Almudena and Portilla Sogorb, Joaquín and Merino De Lucas, Esperanza and Bañuls, Sergio Reus and Martínez, Vicente Boix and Oncina, Livia Giner and Pastor, Carmen Gadea and Portilla Tamarit, Irene and Toledo, Patricia Arcaina and Gómez Sirvent, Juan Luis and Rodríguez Fortúnez, Patricia and Alemán Valls, María Remedios and Del Mar Alonso Socas, María and López Lirola, Ana María and Hernández Hernández, María Inmaculada and Díaz-Flores, Felicitas and Soriano, Vicente and Labarga, Pablo and Barreiro, Pablo and Rivas, Pablo and Blanco, Francisco and Carbonero, Luz Martín and Vispo, Eugenia and Solera, Carmen and Asensi, Victor and Valle, Eulalia and Cartón, José Antonio and Miró, José M and López-Dieguez, María and Manzardo, Christian and Zamora, Laura and Pérez, Iñaki and García, Ma. Teresa and Ligero, Carmen and Blanco, José Luis and García-Alcaide, Felipe and Martínez, Esteban and Mallolas, Josep and Gatell, José M and Rubio, Rafael and Pulido, Federico and Fiorante, Silvana and Llenas, Jara and Rodríguez, Violeta and Matarranz, Mariano and Iribarren, José Antonio and Arrizabalaga, Julio and Aramburu, María José and Camino, Xabier and Rodríguez-Arrondo, Francisco and Von Wichmann, Miguel Angel and Tomé, Lidia Pascual and Goenaga, Miguel Ángel and Bustinduy, Ma. Jesús and Galparsoro, Harkaitz Azkune and Clotet, Bonaventura and Tural, Cristina and Ruiz, Lidia and Miranda, Cristina and Muga, Roberto and Tor, Jordi and Sanvisens, Arantza and Berenguer, Juan and López Bernaldo De Quirós, Juan Carlos and Miralles, Pilar and Ochaíta, Jaime Cosín and Gutiérrez Cuellar, Isabel Á and Ramírez Schacke, Margarita and Padilla Ortega, Belén and ... and CoRIS
PloS one, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e116226
Objectives: We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004-2011 in a... 
INFECTED MEN | EPIDEMIC | OUTBREAK | CLUSTER | SEXUAL TRANSMISSION | MULTIDISCIPLINARY SCIENCES | Prospective Studies | Hepacivirus - immunology | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Risk Factors | Substance Abuse, Intravenous - epidemiology | Male | Incidence | Young Adult | Hepatitis C - diagnosis | Spain - epidemiology | Hepatitis C - epidemiology | Hepatitis C - virology | Sexuality | Substance Abuse, Intravenous - virology | Adult | Female | Poisson Distribution | Aged | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | HIV patients | Hepatitis C virus | HIV (Viruses) | Health aspects | Drug abuse | Sexually transmitted diseases--STD | Sex | Viruses | Infections | Serology | Medical diagnosis | Epidemiology | Risk factors | Hepatitis | Immunology | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Poisson density functions | Statistical analysis | Health risks | Regression analysis | Risk analysis | Patients | Seroconversion | Antiretroviral therapy | CD4 antigen | Hepatitis C | Health risk assessment | Espanya | VIH (Virus) | HIV-positive persons | Persones seropositives | Spain | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article